Faculty Disclosures
| Grant Liu, MD, FAAN |
Dr. Liu has received publishing royalties from a publication relating to health care. |
| Kathryn R. Wagner, MD, PhD |
Dr. Wagner has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd. Dr. Wagner has stock in F. Hoffmann-La Roche. |
| John Vissing, MD |
Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Biosciences. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Italfarmaco. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Biopharma. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson & Johnson (Janssen). Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Edgewise Therapeutics. The institution of Prof. Vissing has received research support from Rigshospitalet. The institution of Prof. Vissing has received research support from UCB Pharma. The institution of Prof. Vissing has received research support from Sanofi. The institution of Prof. Vissing has received research support from Roche. The institution of Prof. Vissing has received research support from AnJii. |
| Benjamin M. Greenberg, MD, FAAN |
Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Husch Blackwell. Dr. Greenberg has stock in GenrAb. Dr. Greenberg has stock in Clene. The institution of Dr. Greenberg has received research support from Anokion. The institution of Dr. Greenberg has received research support from Regeneron. Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care. |
| Robert Avery, DO, MSCE |
Dr. Avery has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ovid. Dr. Avery has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. The institution of Dr. Avery has received research support from NIH. Dr. Avery has received intellectual property interests from a discovery or technology relating to health care. |
| Sean Goretzke, MD |
Dr. Goretzke has nothing to disclose. |
| Amy T. Waldman, MD |
Dr. Waldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SwanBio. An immediate family member of Dr. Waldman has stock in Pfizer. The institution of Dr. Waldman has received research support from Ionis Pharmaceuticals. The institution of Dr. Waldman has received research support from Roche/Genentech. The institution of Dr. Waldman has received research support from Ionis Pharmaceuticals. Dr. Waldman has received publishing royalties from a publication relating to health care. Dr. Waldman has received publishing royalties from a publication relating to health care. |
| Madeline A. Chadehumbe, MD, FAAN |
Dr. Chadehumbe has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Nobias. |
| Ana Carolina Tesi Rocha, MD |
Dr. Tesi Rocha has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Tesi Rocha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Tesi Rocha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Tesi Rocha has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Tesi Rocha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regenxbio. Dr. Tesi Rocha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ITALPHARMACO. Dr. Tesi Rocha has received personal compensation in the range of $500-$4,999 for serving as a Speaker at Symposium with Roche. |
| Jeffrey Statland, MD |
Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ML Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epic Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Armatus . Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vita Therapeutics. Dr. Statland has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex . The institution of Dr. Statland has received research support from NIH. The institution of Dr. Statland has received research support from FSHD Society. The institution of Dr. Statland has received research support from Friends of FSH Research. The institution of Dr. Statland has received research support from FSHD Canada. The institution of Dr. Statland has received research support from MDA. |
| Sona Narula, MD |
Dr. Narula has received personal compensation in the range of $0-$499 for serving as a Consultant for Medscape . |
| Jasper Morrow, MD |
The institution of Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Morrow has received research support from Muscular Dystrophy Association. |
|
No disclosure on file
|
| Cynthia X. Wang, MD |
Dr. Wang has nothing to disclose. |
| Katy Eichinger, PhD, PT, DPT, NCS |
Dr. Eichinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Fulcrum. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avidity. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DyneTherapeutic. Dr. Eichinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TRiNDS. The institution of Dr. Eichinger has received research support from Charcot Marie Tooth Association. The institution of Dr. Eichinger has received research support from Muscular Dystrophy Association. Dr. Eichinger has received intellectual property interests from a discovery or technology relating to health care. |
| Lana Harder, PhD |
Dr. Harder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. |
| Arastoo Vossough, MD |
Dr. Vossough has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Syneos Health. Dr. Vossough has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for DeepSight. Dr. Vossough has received publishing royalties from a publication relating to health care. |
| Sonika Agarwal, MD, FAAN |
Dr. Agarwal has nothing to disclose. |
| Jenna M. Klotz, MD |
Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech Roche. |
| Mackenzie A. Michell-Robinson, MSc |
Mackenzie A. Michell-Robinson has nothing to disclose. |
| Heidemarie Kletzl |
Heidemarie Kletzl has received personal compensation for serving as an employee of Hoffmann-La Roche. |
| Mariam Ishaque |
Ms. Ishaque has nothing to disclose. |
| Mohammad Rohani, MD |
Dr. Rohani has nothing to disclose. |
| Muslima S. Razaqyar |
The institution of Ms. Razaqyar has received research support from National Institutes of Health. |
| Hannah R. Cooper |
Ms. Cooper has nothing to disclose. |
| John R. Sollee |
Mr. Sollee has nothing to disclose. |
| Mahjabeen Ahmed Khan, MBBS |
Dr. Ahmed Khan has nothing to disclose. |
| Angela Dodman |
Angela Dodman has received personal compensation for serving as an employee of F. Hoffman-La Roche Ltd. |
| Eleni Gaki, MD |
Dr. Gaki has received personal compensation for serving as an employee of Roche. Dr. Gaki has received stock or an ownership interest from Roche Products Ltd. |
| Alireza Tavasoli |
Dr. Tavasoli has nothing to disclose. |
| Jonathan M. Towne |
The institution of Mr. Towne has received research support from the American Epilepsy Society (Predoctoral Research Fellowship) and the National Institutes of Health (F31NS131025, T32TR004545, T32GM113896). |
| Manouchehr Amanat |
Mr. Amanat has nothing to disclose. |
| Jonathan A. Barron, MD |
Dr. Amaro-Barron has nothing to disclose. |
| Natasha Bobrowski-Khoury, PhD |
Dr. Bobrowski-Khoury has nothing to disclose. |
| Valentina Zhang, Other |
Miss Zhang has nothing to disclose. |
| Kathryn Gallison, Other |
The institution of Miss Gallison has received research support from Ionis Pharmaceuticals. |
| Julia Macintosh, Other |
Ms. Macintosh has nothing to disclose. |
| Joshua Joung, Other |
Mr. Joung has nothing to disclose. |
| Birgit Jaber |
No disclosure on file
|
| Florence Chiang |
No disclosure on file
|
| Peter Fox |
No disclosure on file
|
| Walter Faig |
Walter Faig has received personal compensation for serving as an employee of Westat. |